Verastem Non-GAAP EPS of -$0.54 beats by $0.07, revenue of $11.2M beats by $5.44M

4 hours ago 1

Verastem press release (VSTM): Q3 Non-GAAP EPS of -$0.54 beats by $0.07.
Revenue of $11.24M beats by $5.44M.
Ended Q3 2025 with $137.7 million in cash and cash equivalents; with expected product revenue and exercise of cash warrants, Company cash runway would extend into the second half of 2026.